stella
beta
Phase 2 Study of Combination Tivozanib and Nivolumab in Advanced Non-Clear Cell Renal Cell Carcinoma — Stella
Recruiting
Back to Renal Cell Carcinoma trials
Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.
Trial locations
(5 sites)
United States
Beth Israel Deaconess Medical Center, Boston, Massachusetts
Dana-Farber Cancer Institute, Boston, Massachusetts
University of Michigan, Ann Arbor, Michigan
UT Southwestern Medical Center, Dallas, Texas
M D Anderson Cancer Center, Houston, Texas
View full record on ClinicalTrials.gov